Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer

Background: CD44 and ALDH1 have been recognized as the most widely used markers to identify breast cancer stem cells (BCSCs). However, limited to tissue sample and rare population, BCSCs have always been not easily detected. We aimed to measure CD44 and ALDH1A1 (major contributor to ALDH1 activity)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yanan, Lyu, Ning, Wu, Jiali, Tang, Hailin, Xie, Xinhua, Yang, Lu, Li, Xing, Wei, Weidong, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215997/
https://www.ncbi.nlm.nih.gov/pubmed/30405844
http://dx.doi.org/10.7150/jca.28032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215997/
https://www.ncbi.nlm.nih.gov/pubmed/30405844
http://dx.doi.org/10.7150/jca.28032

Ejemplares similares